Yagya Therapy as supportive care in cancer patients improved quality of life: Case studies
Download full-text PDF
View full-text HTML


Yagya Therapy
Quality of life
herbal medicinal smoke

How to Cite

Mishra, A., Batham, L., & Shrivastava, V. (2018). Yagya Therapy as supportive care in cancer patients improved quality of life: Case studies. Interdisciplinary Journal of Yagya Research, 1(1), 26 - 33. https://doi.org/10.36018/ijyr.v1i1.3


Abstract. Cancer is becoming leading cause of death around the world. India has limited infrastructure and facility to fight the disease. In addition, side effects of current standard therapies like chemotherapy and radiation therapy severely hamper the quality of life (QOL) of patients. Alternative supportive therapies are a dire need, not only to reduce current therapeutic burden, but also to reduce the side effects, and deteriorating QOL of cancer patients. Yagya Therapy is an ancient Vedic therapeutic model, which allows pulmonary inhalation of medeicinal-smoke of multi-herbs combination, generated through its oblation in fire, along with the chanting of mantras. The study attempted to evaluate QOL of life of three cancer patients (breast cancer, mouth cancer and chronic myeloid leukemia), who were prescribed to inhale medicinal-smoke generated using specifically prepared multi-herbs combination as part of Yagya Therapy by Center for Ayurveda Studies at Dev Sanskriti Vishwavidyalaya. Patients continued their normal regime of allopathic treatment and used Yagya Therapy as supportive care. They were assessed for QOL using self-prepared 10-scale questionnaire. All three patients reported improvement in their QOL after taking Yagya Therapy for 12, 7 and 2 months, respectively. Averages of % improvement in all available individual conditions on 10-scale questionnaire, including physical and psychological complaints were 75%, 41.67%, and 40%, respectively. The study indicated the potential of Yagya Therapy using specific multi-herbs herbal preparation as supportive care for improving QOL of cancer patients taking standard allopathic treatments.

Download full-text PDF
View full-text HTML


Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Heal. 2016;4(9):e609–16. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2214109X16301437

Mallath MK, Taylor DG, Badwe RA, Rath GK, Shanta V, Pramesh CS, et al. The growing burden of cancer in India: epidemiology and social context. Lancet Oncol. 2014;15(6):e205–12. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1470204514701159

Urruticoechea A, Alemany R, Balart J, Villanueva A, Viñals F, Capellá G. Recent advances in cancer therapy: an overview. Curr Pharm Des. 2010;16(1):3–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20214614

Yin S-Y, Wei W-C, Jian F-Y, Yang N-S. Therapeutic applications of herbal medicines for cancer patients. Evid Based Complement Alternat Med. 2013:302426. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23956768

Chabner BA, Roberts TG. Chemotherapy and the war on cancer. Nat Rev Cancer. 2005;5(1):65–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15630416

Ramirez LY, Huestis SE, Yap TY, Zyzanski S, Drotar D, Kodish E. Potential chemotherapy side effects: what do oncologists tell parents? Pediatr Blood Cancer. 2009;52(4):497–502. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19101994

Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, et al. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends. 2010;4(6):297–307. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21248427

Metri K, Bhargav H, Chowdhury P, Koka PS. Ayurveda for chemo-radiotherapy induced side effects in cancer patients. J Stem Cells. 2013;8(2):115–29. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24698988

Brahmavarchas, editor. Yagya Chikitsa. 1st ed. Shri Vedmata Gayatri Trust, Shantikunj, Haridwar (Uttarakhand), 249411, India; 2010:1-368

Pandya P. Applied Science of Yagya for Health & Environment. Shri Vedmata Gayatri Trust, Shantikunj, Haridwar (Uttarakhand), 249411, India; 2009:1-117. Available from: www.awgp.org

Joshi RR, Raghuvanshi M, Pandya P. Yagyopathy versus oral and iv drug administration: evaluation for pulmonary tuberculosis using compartment modeling. J Biol Syst. 2006;14(03):463–89. Available from: http://www.worldscientific.com/doi/abs/10.1142/S0218339006001891

Raghuvanshi M, Pandya P, Joshi RR. In-vitro testing of an ethnobotanical inhalation therapy against pulmonary tuberculosis. Phytotherapie. 2009;7(5):243–9.

Sharma S. Yagya Chikitsa Dwara Manasik Swasthya Par Padane Vale Prabhav Ka Adhyayan (Hindi)(Dissertation). Dev Sanskriti Vishwavidyalaya, Shantikunj, Haridwar, Uttarakhand, India. 2009.

Sharma P, Khokhar CP, Manchanda SC, Sharma N. Yagya Therapy for Managing Inferiority & Insecurity feeling of HIV + / AIDS Patients. Dev Sanskriti Interdiscip Int J. 2012;01:70–7.

Raghuvanshi M, Pandya P, Joshi RR. Yagyopathic Herbal Treatment of Pulmonary Tuberculosis Symptoms: A Clinical Trial. Altern Complement Ther. 2004;10(2):101–5. Available from: http://www.liebertonline.com/doi/abs/10.1089/107628004773933352

Hu X, Yang F, Liao Y. Pharmacokinetic considerations of inhaled pharmaceuticals for systemic delivery. Curr Pharm Des. 2016;22(17):2532–48

Mohagheghzadeh A, Faridi P, Shams-Ardakani M, Ghasemi Y. Medicinal smokes. J Ethnopharmacol. 2006;108(2):161–84

Acharya PSS, editor. Sankshipt Gayatri hawan vidhi (Hindi). Revision. Yug nirman yojana vistar trust, Gayatri Tapobhumi, Mathura; 2012. 1-49

Sharma P. Dravyaguna Vijnana - Volume II (Hindi). Chaukhambha Bharati Academy, Varanasi, Uttar Pradesh, India. 2001.

Baliga MS, Jimmy R, Thilakchand KR, Sunitha V, Bhat NR, Saldanha E, et al. Ocimum sanctum L (Holy Basil or Tulsi) and its phytochemicals in the prevention and treatment of cancer. Nutr Cancer. 2013;65(sup1):26–35. Available from: http://www.tandfonline.com/doi/abs/10.1080/01635581.2013.785010

Manjeshwar Shrinath Baliga. Alstonia scholaris Linn R Br in the treatment and prevention of cancer: past, present, and future. Integr Cancer Ther. 2010;9(3):261–9. Available from: http://journals.sagepub.com/doi/10.1177/1534735410376068

Palliyaguru DL, Singh S V, Kensler TW. Withania somnifera: From prevention to treatment of cancer. Mol Nutr Food Res. 2016;60(6):1342–53. Available from: http://doi.wiley.com/10.1002/mnfr.201500756

Bag A, Bhattacharyya SK, Chattopadhyay RR. The development of Terminalia chebula Retz. (Combretaceae) in clinical research. Asian Pac J Trop Biomed. 2013;3(3):244–52. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2221169113600593

Wang ZY, Nixon DW. Licorice and cancer. Nutr Cancer. 2001;39(1):1–11. Available from: http://www.tandfonline.com/doi/abs/10.1207/S15327914nc391_1

Mishra S, Aeri V, Gaur PK, Jachak SM. Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn. Biomed Res Int. 2014:808302. Available from: http://www.hindawi.com/journals/bmri/2014/808302/

Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology. J Clin Oncol. 2000;18(13):2505–14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10893280

Kesarwani K, Gupta R, Mukerjee A. Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed. 2013;3(4):253–66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23620848

Ndao DH, Ladas EJ, Cheng B, Sands SA, Snyder KT, Garvin JH, et al. Inhalation aromatherapy in children and adolescents undergoing stem cell infusion: results of a placebo-controlled double-blind trial. Psychooncology. 2010;3:247–254.

Potter P, Eisenberg S, Cain KC, Berry DL. Orange Interventions for Symptoms Associated With Dimethyl Sulfoxide During Stem Cell Reinfusions. Cancer Nurs. 2011;34(5):361–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21372706

Brahmavarchas, editor. Yagya ka gyan vigyan (Pt. Shriram Sharma Acharya Vangmay 25). Akhand Jyoti Sansthan, Mathura - 281003; 1994. Available from: www.literature.awgp.org

Pandya NT, Jani P, Vanza J, Tandel H. Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension. Colloids Surfaces B Biointerfaces. 2018;165:37–44. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0927776518300808

Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.